Dr. Martin Adrian Koch

Dr. Martin Adrian Koch

Senior Associate

Email [email protected]​hoganlovells.com

Phone +49 211 13 68 138

Fax +49 211 13 68 100

LanguagesEnglish, German

Practice groupIntellectual Property, Media, and Technology

For our clients Martin Koch coordinates international patent disputes and represents them in German patent infringement and parallel nullity proceedings in all fields of technology. Our clients especially like his sharp legal advocacy and methodical and business-focused approach.

One of his areas of focus is the pharmaceutical and medical devices industry. He has worked on various matters for several of our clients and gained in-depth knowledge of the industry and market-specific legal questions. This also includes the interface with regulatory and competition law. 

Our clients also turn to Martin for his broad patent litigation experience in the areas of telecommunications, chemistry, software and mechanics and his ability to effectively coordinate even the largest cases with international internal teams and outside counsel.

Martin has in-depth knowledge of Legal Tech products and processes and acts as the Legal Tech Representative for the IPMT practice group in Germany. In this role Martin acts as the interface between his Practice Area and the Legal Tech programming development team of Hogan Lovells. He coordinates and supervises the development of Legal Tech products from idea to market launch.

Awards and recognitions


Europe Cross-border Patent Litigation Team of the Year - For Eli Lilly and Company (Pemetrexed patent)
Managing IP EMEA Awards

Education and admissions


Second State Exam in Law, Higher Regional Court of Dusseldorf, 2017

Dr. iur., University of Freiburg, 2016

First State Exam in Law, University of Bayreuth, 2012

Business Lawyer, University of Bayreuth, 2012


German Association for the Protection of Intellectual Property (GRUR)

Representative experience

Representing Eli Lilly in numerous preliminary injunction, main action and nullity proceedings regarding its chemotherapy drug Alimta®.

Advising major Swiss pharmaceutical company on pan-European strategy and coordinating pan-European enforcement of patents against market entry of biosimilar products.

Acting for a Germany-based international company in a patent infringement case in the area of explosives.

Acting for a Chinese electronics company in the area of telecommunication standards. 

Loading data